A Post-Marketing Safety Study to Evaluate the Safety of VELSIPITY® (Etrasimod) Exposure During Pregnancy (C5041043) First published 03/09/2025 Last updated 03/09/2025 EU PAS number:EUPAS1000000672 Study Planned